Shichong Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shichong Yu has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Xiaoyun Chai
Second Military Medical University
4 shared publications- Qing-Guo Meng
School of Pharmacy, Yantai University, Yantai 264005, China
3 shared publications - Qiuye Wu
Department of Organic Chemistry, College of Pharmacy, Second Military Medical University, Guohe Road 325, Shanghai 200433, P.R. China
3 shared publications - Yan Zou
School of Pharmacy, Second Military Medical University, Shanghai, 200433, PR China
3 shared publications - Yuanying Jiang
Department of Pharmacy, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, China
3 shared publications - Qingjie Zhao
State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Shanghai Frontiers Science Center for TCM Chemical Biology, Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, PR China
2 shared publications
Latest Publications
- 6 July 2025
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 62 (8) , 535-545
Synthesis of Novel 1,2,3‐Triazole Derivatives via Click Chemistry and Evaluation of Their Antifungal Activity
Due to clinical demands, there remains a need for new triazole antifungal compounds to broaden the antifungal spectrum and enhance therapeutic efficacy. In this paper, we have developed an effective method for obtaining triazole compounds with 1,2,3‐triazole groups introduced into their side chains via click chemistry, targeting the active site of cytochrome P450 14α‐demethylase (CYP51). In vitro antifungal activity tests of the title compounds against three human pathogenic fungi demonstrated that this class of compounds exhibited good antifungal activity. Notably, compound 2d exhibits superior antifungal activity compared to fluconazole against Candida albicans SC5314 (with the MIC value of ≤ 0.125 μg/mL) and Cryptococcus neoformans 32609 (with the MIC value of 2 μg/mL), meriting further investigation. Molecular docking results indicated that the introduced 1,2,3‐triazole rings in the side chains formed π–π stacking interactions with Tyr118 of CYP51, along with additional hydrogen bonds. This paper provides a method for rapidly modifying the side chains of triazole antifungal drugs in the future to obtain compounds with further enhanced activity.
- 6 July 2025
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 62 (8) , 535-545
Synthesis of Novel 1,2,3‐Triazole Derivatives via Click Chemistry and Evaluation of Their Antifungal Activity
Due to clinical demands, there remains a need for new triazole antifungal compounds to broaden the antifungal spectrum and enhance therapeutic efficacy. In this paper, we have developed an effective method for obtaining triazole compounds with 1,2,3‐triazole groups introduced into their side chains via click chemistry, targeting the active site of cytochrome P450 14α‐demethylase (CYP51). In vitro antifungal activity tests of the title compounds against three human pathogenic fungi demonstrated that this class of compounds exhibited good antifungal activity. Notably, compound 2d exhibits superior antifungal activity compared to fluconazole against Candida albicans SC5314 (with the MIC value of ≤ 0.125 μg/mL) and Cryptococcus neoformans 32609 (with the MIC value of 2 μg/mL), meriting further investigation. Molecular docking results indicated that the introduced 1,2,3‐triazole rings in the side chains formed π–π stacking interactions with Tyr118 of CYP51, along with additional hydrogen bonds. This paper provides a method for rapidly modifying the side chains of triazole antifungal drugs in the future to obtain compounds with further enhanced activity.
- Open Access
- 1 March 2015
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. 9, 1459-67
Design, synthesis, and antifungal activities of novel triazole derivatives containing the benzyl group
In previous studies undertaken by our group, a series of 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted-2-propanols (1a–r), which were analogs of fluconazole, was designed and synthesized by click chemistry. In the study reported here, the in vitro antifungal activities of all the target compounds were evaluated against eight human pathogenic fungi. Compounds 1a, 1q, and 1r showed the more antifungal activity than the others.
- 1 March 2015
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. 9, 1459-67
Open AccessDesign, synthesis, and antifungal activities of novel triazole derivatives containing the benzyl group
In previous studies undertaken by our group, a series of 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted-2-propanols (1a–r), which were analogs of fluconazole, was designed and synthesized by click chemistry. In the study reported here, the in vitro antifungal activities of all the target compounds were evaluated against eight human pathogenic fungi. Compounds 1a, 1q, and 1r showed the more antifungal activity than the others.
- 17 May 2014
- Published by Springer Nature in Archives of Pharmacal Research
- Vol. 38 (4) , 470-479
Synthesis and biological evaluation of novel fluconazole analogues bearing 1,3,4-oxadiazole moiety as potent antifungal agents
A novel series of fluconazole based mimics incorporating 1,3,4-oxadiazole moiety were designed and synthesized. All the title compounds were characterized by 1H-NMR, 13C-NMR, and Q-TOF-MS. Preliminary results revealed that most of analogues exhibited significant antifungal activity against seven pathogenic fungi. Compounds 9g and 9k (MIC80 ≤ 0.125 μg/mL, respectively) were found more potent than the positive controls itraconazole and fluconazole as broad-spectrum antifungal agents. The observed docking results showed that the 1,3,4-oxadiazole moiety enhanced the affinity binding to the cytochrome P450 14α-demethylase (CYP51).
- 17 May 2014
- Published by Springer Nature in Archives of Pharmacal Research
- Vol. 38 (4) , 470-479
Synthesis and biological evaluation of novel fluconazole analogues bearing 1,3,4-oxadiazole moiety as potent antifungal agents
A novel series of fluconazole based mimics incorporating 1,3,4-oxadiazole moiety were designed and synthesized. All the title compounds were characterized by 1H-NMR, 13C-NMR, and Q-TOF-MS. Preliminary results revealed that most of analogues exhibited significant antifungal activity against seven pathogenic fungi. Compounds 9g and 9k (MIC80 ≤ 0.125 μg/mL, respectively) were found more potent than the positive controls itraconazole and fluconazole as broad-spectrum antifungal agents. The observed docking results showed that the 1,3,4-oxadiazole moiety enhanced the affinity binding to the cytochrome P450 14α-demethylase (CYP51).
- Open Access
- 1 April 2014
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. 8, 383-90
Triazole derivatives with improved in vitro antifungal activity over azole drugs
A series of triazole antifungal agents with piperidine side chains was designed and synthesized. The results of antifungal tests against eight human pathogenic fungi in vitro showed that all the compounds exhibited moderate-to-excellent activities. Molecular docking between 8d and the active site of Candida albicans CYP51 was provided based on the computational docking results. The triazole interacts with the iron of the heme group. The difluorophenyl group is located in the S3 subsite and its fluorine atom (2-F) can form H-bonds with Gly307. The side chain is oriented into the S4 subsite and formed hydrophobic and van der Waals interactions with the amino residues. Moreover, the phenyl group in the side chain interacts with the phenol group of Phe380 through the formation of π–π face-to-edge interactions.
- 1 April 2014
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. 8, 383-90
Open AccessTriazole derivatives with improved in vitro antifungal activity over azole drugs
A series of triazole antifungal agents with piperidine side chains was designed and synthesized. The results of antifungal tests against eight human pathogenic fungi in vitro showed that all the compounds exhibited moderate-to-excellent activities. Molecular docking between 8d and the active site of Candida albicans CYP51 was provided based on the computational docking results. The triazole interacts with the iron of the heme group. The difluorophenyl group is located in the S3 subsite and its fluorine atom (2-F) can form H-bonds with Gly307. The side chain is oriented into the S4 subsite and formed hydrophobic and van der Waals interactions with the amino residues. Moreover, the phenyl group in the side chain interacts with the phenol group of Phe380 through the formation of π–π face-to-edge interactions.
- 1 January 2014
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 24 (1) , 192-194
Synthesis and evaluation of novel azoles as potent antifungal agents
- 1 January 2014
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 24 (1) , 192-194
Synthesis and evaluation of novel azoles as potent antifungal agents
- 3 May 2013
- Published by Springer Nature in Archives of Pharmacal Research
- Vol. 36 (10) , 1215-1222
Synthesis and antifungal activity of the novel triazole derivatives containing 1,2,3-triazole fragment
A series of fluconazole analogues containing 1,2,3-triazole fragment have been designed and synthesized on the basis of the active site of the cytochrome P450 14α-demethylase (CYP51). Their structures were characterized by 1H NMR, 13C NMR and LC–MS. The MIC80 values indicate that the target compounds 1a–r showed higher activities against nearly all the fungi tested to some extent except against Aspergillus fumigatus. Compounds 1c, e, f, l and p showed 128 times higher activity (with the MIC80 value of 0.0039 mg/mL) than that of fluconazole against Candida albicans and also showed higher activity than that of the other positive controls.
- 3 May 2013
- Published by Springer Nature in Archives of Pharmacal Research
- Vol. 36 (10) , 1215-1222
Synthesis and antifungal activity of the novel triazole derivatives containing 1,2,3-triazole fragment
A series of fluconazole analogues containing 1,2,3-triazole fragment have been designed and synthesized on the basis of the active site of the cytochrome P450 14α-demethylase (CYP51). Their structures were characterized by 1H NMR, 13C NMR and LC–MS. The MIC80 values indicate that the target compounds 1a–r showed higher activities against nearly all the fungi tested to some extent except against Aspergillus fumigatus. Compounds 1c, e, f, l and p showed 128 times higher activity (with the MIC80 value of 0.0039 mg/mL) than that of fluconazole against Candida albicans and also showed higher activity than that of the other positive controls.
- Open Access
- 25 October 2010
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 76 (6) , 496-504
Synthesis, Molecular Docking, and Biological Evaluation of Novel Triazole Derivatives as Antifungal Agents
Twenty-eight novel triazole derivatives (compounds 1a-v, 2a-f) have been synthesized for structure-activity relationship studies as antifungal agents. The compounds were designed on the basis of the structure of fluconazole and molecular modeling of the active site of the cytochrome P450 14α-demethylase (CYP51). All of them are reported for the first time. Their chemical structures are characterized by (1) H NMR, (13) C NMR, LC-MS, and elemental analysis. The antifungal activities have been evaluated in vitro by measuring the minimal inhibitory concentrations (MICs). Compounds 1a-v exhibited higher activity against nearly all fungi tested except Aspergillus fumigatus (A. fum) than fluconazole (FCZ). The computational molecular docking experiments indicated that the inhibition of CYP51 involves a coordination bond with iron of the heme group, a hydrophilic H-bonding region, a hydrophobic region, and a narrow hydrophobic binding cleft.
- 25 October 2010
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 76 (6) , 496-504
Open AccessSynthesis, Molecular Docking, and Biological Evaluation of Novel Triazole Derivatives as Antifungal Agents
Twenty-eight novel triazole derivatives (compounds 1a-v, 2a-f) have been synthesized for structure-activity relationship studies as antifungal agents. The compounds were designed on the basis of the structure of fluconazole and molecular modeling of the active site of the cytochrome P450 14α-demethylase (CYP51). All of them are reported for the first time. Their chemical structures are characterized by (1) H NMR, (13) C NMR, LC-MS, and elemental analysis. The antifungal activities have been evaluated in vitro by measuring the minimal inhibitory concentrations (MICs). Compounds 1a-v exhibited higher activity against nearly all fungi tested except Aspergillus fumigatus (A. fum) than fluconazole (FCZ). The computational molecular docking experiments indicated that the inhibition of CYP51 involves a coordination bond with iron of the heme group, a hydrophilic H-bonding region, a hydrophobic region, and a narrow hydrophobic binding cleft.